Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?

Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinlechner, Barbara, Kargl, Gabriele, Schlömmer, Christine, Holaubek, Caroline, Scheriau, Georg, Eichinger, Sabine, Gratz, Johannes, Rössler, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184338/
https://www.ncbi.nlm.nih.gov/pubmed/34194852
http://dx.doi.org/10.1155/2021/6624682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184338/
https://www.ncbi.nlm.nih.gov/pubmed/34194852
http://dx.doi.org/10.1155/2021/6624682

Ejemplares similares